Financial News
Jazz Pharma Plc (NQ: JAZZ )
113.87
-0.68
(-0.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Jazz Pharma Plc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://g.foolcdn.com/editorial/images/773926/three-one-hundred-dollar-bills-cash-money-buried-sand-sunset-beach-summer-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/ezgif-2-a9d7c7d0e4.jpeg?width=1200&height=800&fit=crop)
How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
March 25, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
March 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
February 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Evaluating Jazz Pharmaceuticals: Insights From 7 Financial Analysts
January 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Decoding 6 Analyst Evaluations For Jazz Pharmaceuticals
January 03, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Charlotte-Figi.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://g.foolcdn.com/editorial/images/766368/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
February 24, 2024
Via The Motley Fool
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2021/02/marijuana-cannabis-stocks-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Jazz Pharmaceuticals
November 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/Photo--EmilyPaxhia-PoseidonAssetManageme.jpeg?width=1200&height=800&fit=crop)
The Queen Of Marijuana Investing Used Psychology To Launch Her Successful Cannabis Investment Fund
February 14, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://investorplace.com/wp-content/uploads/2022/04/buy_the_dip_stocks_1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://g.foolcdn.com/editorial/images/763478/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Science--Safety--Research--Technology-An.jpeg?width=1200&height=800&fit=crop)
Japanese University Will Research Marijuana's Medical Uses In First-Of-Its-Kind Collaboration With Australian Company
January 31, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://g.foolcdn.com/editorial/images/761571/getty-laptop-serious-headphones-listening-podcast.jpg)
![](https://g.foolcdn.com/editorial/images/761082/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/data-charts.png?width=1200&height=800&fit=crop)
US Stocks Set To Open Weaker As Traders Eye Key Main Street Events: Analyst Sees Buying Opportunity On 'Stunning' Earnings Expectations
January 03, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_01.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/22/jazz.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/758515/cash-money-five-hundred-dollars-invest-retire-stock-market-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/06/david-edelstein-n4dbvtudikw-unsplash-1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/30/cannabis_oil_regulationshutterstock13.jpg?width=1200&height=800&fit=crop)
Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
November 30, 2023
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.